Gastric dysplasia: classification and clinical characteristics;Displasia gastrica: Classificazioni e aspetti clinici

Minerva Gastroenterologica e Dietologica

Volumn 50, Issue 4, 2004, Pages 331-338

  Vindigni, C ^a   Galgani, P ^b,c  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b USL 7   (Italy)

^c NONE   (Italy)

Author keywords

Precancerous conditions; Stomach neoplasms, diagnosis; Stomach neoplasms, pathology

Indexed keywords

CANCER CLASSIFICATION; CANCER GRADING; DISEASE CLASSIFICATION; GASTROINTESTINAL DYSPLASIA; REVIEW; STOMACH CANCER; STOMACH TUMOR; CLASSIFICATION; FOLLOW UP; HUMAN; STOMACH DISEASE;

FOLLOW-UP STUDIES; HUMANS; STOMACH DISEASES;

EID: 20644452651     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Nishi M, Ishihara S, Nakajima T, Ohta K, Ohyama S, Ohta H. Chronological changes of charateristics of early gastric cancer and therapy: experience in the Cancer Institute Hospital of Tokyo 1950-1994. J Cancer Res Clin Oncol 1995;121:535-41.
2. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serk-Hanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 1980;33:711-21.
3. Ming SC, Bajtai A, Correa P, Elster K, Jarvi OH, Munoz N et al. Gastric dysplasia significance and pathologic criteria. Cancer 1984;54:1794-801.
4. Nakamura K, Sugano H, Takagi K. Histopathological study on early carcinoma of the stomach: criteria for diagnosis of atypical epithelium. Gann 1966;57:613-20.
5. Nagayo T. Histological diagnosis of biopsied gastric mucosa with special reference to that of borderline lesions. Gann 1971;11:245-56.
6. Grundmann E. Histologic type and possible initial stages in early gastric carcinoma. Beitr Path Bd 1975;154:256-80.
7. Serk-Hanssen A. Precancerous lesions of the stomach. Scand J Gastroenterol 1979;14 (Suppl 54):104-5.
8. Riddell RH, Goldmann H, Ransohoff DF. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical application. Hum Pathol 1983;14:931-68.
9. Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol 1997;28:127-33.
10. Schlemper RJ, Itabashi M, Kato Y, Lewin K, Riddell RH, Shimoda T et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997;349:1725-9.
11. Schlemper RJ, Kato Y, Stolte M. Well differentiated adenocarcinoma or dysplasia of the gastric epithelium: rationale for a new classification system. Verh Dtsch Ges Path 1999;83:62-70.
12. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM et al. The Vienna Classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
13. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin KJ et al. Gastric dysplasia. The Padova international classification. Am J Surg Pathol 2000;24:167-76.
14. Lauwers GY, Riddell RH. Gastric epithelial dysplasia. Gut 1999;45:784-90.
15. Caselli M, Freguglia F, Greco F, Ruina M, Alvisi V. Terminology and gastric epithelial dysplasia. Lancet 2000;356:1528.
16. Clouston AD. Timely topic: premalignant lesions associated with adenocarcinoma of the upper gastrointestinal tract. Pathology 2001;33:271-7.
17. Stolte M. The new Vienna Classification of the epithelial neoplasia of the gastrointestinal tract: advantage and disadvantages. Virchows Arh 2003;442:99-106.
18. Schlemper RJ, Kato Y, Stolte M. Review of histological classification of gastrointestinal neoplasia: differences in diagnosis of early carcinoma between Japanese and Western pathologists. J Gastroenterol 2001;36:445-56.
19. Fenoglio-Preiser CM. Gastrointestinal Pathology. Philadelphia: Lippincott-Raven; 1999.
20. Rugge M, Farinati F, Baffa R, Sonego F, Di Mario F, Leandro G et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Gastroenterology 1994;107:1288-96.
21. Munoz M, Franceschi S. Epidemiology of gastric cancer and prospective for prevenction. Salud Pub Mex 1997;39:318-30.
22. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
23. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992;52:6735-40.
24. Filipe MI, Potet F, Bogomoletz WV. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centers. Gut 1985;26:1319-26.
25. Filipe MI, Munoz N, Matko I. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9.
26. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000;95:1431-8.
27. Rugge M, Leandro G, Farinati F, Di Mario F, Sonego F, Cassaro M et al. Gastric epithelial dysplasia. How clinicopathological background relates to management. Cancer 1995;76:376-82.
28. Ming SC. The importance of follow-up studies in gastric displasia: the pathologist's view. Endoscopy 1993;25:294-5.
29. Correa P, Miller MJS. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998;54:151-62.
30. Kabu Y, Kawai K. The clinical significance of gastric dysplasia: the gastroenterologist's view. Endoscopy 1993;25:296-7.
31. Haber M. Histologic precursor of gastrointestinal tract malignancy. Gastroenterol Clin North Am 2002;31:395-419.
32. Misdraji J, Lauwers GY. Gastric epithelial dysplasia. Semin Diagn Pathol 2002;19:20-30.
33. Okabayashi T, Gotoda T, Kondo H, Ono H, Oda I, Fujishiro M et al. Usefulness of indigo carmine chromoendoscopy and endoscopic clipping for accurate preoperative assessment of proximal gastric cancer. Endoscopy 2000;32:62.
34. Tytgat GNJ, Classen M, Waye JD, Nakazawa S. Practice of therapeutic endoscopy. Philadelphia: WB Saunders; 2000.
35. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Lara-Santos L, Guilherme M, Moreira-Dias L et al. Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest Endosc 2003;57:498-554.
36. Fertitta AM, Comin U, Terrazzi V, Minoli G, Zambelli A, Cannatelli G et al. Clinical significance of gastric dysplasia: a multicenter follow-up study. Endoscopy 1993; 25:265-8.
37. Cornaggia M, Testino G. La displasia epiteliale gastrica. Giorn Chir 2000;21:349-52.
38. Pascal RR, Santeusanio G, Spagnoli LG. Early gastric cancer and gastric dysplasia. Ann It Chir 1996;67:391-7.
39. Testino G, Cornaggia M, Sorveglianza endoscopica delle modificazioni precancerose dello stomaco. Minerva Chir 2001;56:69-76.
40. Rugge M, Cassaro M, Di Mario F, Leo G, Leandro G, Russo VM et al. The long term outcome of gastric non invasive neoplasia. Gut 2003;52:1111-6.
41. Koch HK, Oehelert M, Oehelert W. An evaluation of gastric dysplasia in the years 1986 and 1987. Path Res Pract 1990;186:80-4.
42. De Dombal FT, Price AB, Thompson H, Williams GT, Morgan AG, Softley A et al. The British Society of Gastroenterology early gastric cancerdysplasia survey: an interim report. Gut 1990;31:115-20.
43. Farinati F, Rugge M, Di Mario F, Valiante F, Baffa R. Early and advanced gastric cancer in the follow-up of moderate and severe gastric displasia patients. A prospective study. Endoscopy 1993;25:261-4.
44. Coma del Corral MJ, Pardo-Mindan FJ, Razquin S, Ojeda C. Risk of cancer in patients with gastric dysplasia. Cancer 1990;65:2078-85.
45. Inoue H. Treatment of esophageal and gastric tumors Endoscopy 2001;33:119-25.
46. Weinstein WM, Goldstein NS. Gastric dysplasia and its management. Gastroenterology 1994;107:1543-5.
47. Valle J, Gisbert JP. Helicobacter pylori infection and precancerous lesions of the stomach. Hepatogastroenterol 2001;48:1548-51.
48. O'Mahoney S. Endoscopic mucosal resection for early gastric cancer. Gut 2001;48:151-2.
49. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001;48:215-9.
50. Borody TJ, Clark IW, Andrews P, Hugh TB, Shortis NP. Eradication of Helicobacter pylori may not riverse severe gastric displasia. Am J Gastroenterol 1995;90:498-9.
51. Ching CK. Can we justify resecting all gastric epithelial dysplasyic lesions? Gastroenterology 1995;108:955-6.
52. Correa P, Fonthan ETH, Bravo JC, Bravo LE, Ruiz B, Zarama G et al. Chemoprevention of gastric dysplasia: randomised trial of antioxidant supplements and antihelicobacter pylori therapy. J Natl Canc Inst 2000;92:1881-8.
53. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M et al. Helicobacter pylori infection and development of gastric cancer. N Engl J Med 2001;345:784-9.
54. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
55. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002;51:130-1.